Dexcom has put a number to its patient-base: apparently 140k-150k PWDs are using the Dexcom CGM system around the world. About a quarter of those are from outside the U.S., which is why Dexcom plans to expand its international presence by establishing a European headquarters in Edinburgh, Scotland and expand the European team on all fronts. As of Monday 16th May, Advanced Therapeutics will no longer be the Dexcom distributer in the UK.
Dexcom CEO Kevin Sayer says that by the end of 2016 or early 2017, they’ll be launching a new, smaller G5 transmitter as well as a one-button-push insertion system. They’re also working on a new receiver, one that we’ve heard could be a touchscreen design and have an even more modern look than the iPod-style rectangle receiver made for the G4 launch in 2012.
“Over the next several years, we expect the transition to a direct commercial presence in multiple European countries, including the UK. We continue to believe that reimbursement could come in Germany and France and the UK in the near future and we will be ready to capitalize on that opportunity,” continued Sayer.
Animas will continue their relationship with Dexcom and supply through them will continue unchanged.
Expectations are that by the end of 2016 or early 2017, Dexcom will be launching a new smaller G5 transmitter as well as a one-button-push insertion system. They are also working on a new receiver, one that could be a touchscreen design and have an even more modern look than the iPod-style rectangle receiver made for the G4 launch in 2012.
Letter to patients:
12 May 2016
Dear Valued Customer,
Dexcom is proud to announce that we will now bring our products and services directly to you in the UK.
Effective 16 May 16, you will no longer be required to go through a distributor to purchase Dexcom Continuous Glucose Monitoring (CGM) Systems. Dexcom will now deliver directly to you to ensure expedited service and a quality product that you have grown to depend on to help manage your glucose levels.
By working directly with our customers, it provides us with new opportunities to ensure our UK customers have a great experience with Dexcom products and service. Not only will we be able to implement some changes based on your feedback, you will also gain access to some levels of support that only we can provide.
Some benefits that you can look forward to include:
– Enhanced customer service
– Reduced pricing to allow more patients access to Dexcom CGM
– Better access to technical support so you can speak directly with Dexcom for a quicker resolution
As we expand our UK offices, you will experience some of the benefits that we are implementing immediately – such as improved pricing. Other benefits will be rolled out as we expand our team and outreach. We look forward to notifying you of the enhancements as they become available.
Finally, by servicing our customers directly, we can now truly hear what you need from us. Dexcom’s mission is Empowering people to take control of diabetes and our expanded UK presence, along with the goal to have our CGM product available to more people, will enable us to achieve our mission.
We look forward to hearing from you and helping you gain the maximum experience with our products. Our contact numbers, new pricing list and opening times are contained below.
Yours,
Karen Baxter
Country Manager UK & Ireland
For patients with the Vibe, Animas CGM prices are listed here.
Copy and paste contact details for Dexcom:
For phone orders you may contact us by the numbers below from 1pm to 6pm BST:
020 7139 1980
0330 088 7877
0800 031 5761
Email (for orders): gb.sales@dexcom.com
For technical support you may contact us by the numbers below 24/7:
0131 516 0470
0330 088 7879
0800 031 5763
*** Like any changes there can be teething difficulties, we are hearing of some with the new Dexcom headquarters. Please be patient, if possible have your customer details and funding information to hand before calling them. I’m sure they are working hard to smooth out any issues asap for their customers.